Truist Securities analyst Neal Dingmann maintains Devon Energy (NYSE:DVN) with a Buy and raises the price target from $110 to $115.
See Why Molecular Partners Shares Dropped To 52-Week Low During Tuesday Premarket?
Molecular Partners AG (NASDAQ: MOLN) has announced that a planned futility analysis of ensovibep in the Phase 3 ACTIV-3 study has not met the thresholds required to continue enrollment of hospitalized adults with COVID-19.
